Cite Filings / FDMT / 0000950170-24-012429

Feed Companies Filings Check

Sign in

3/A

Filing

4D Molecular Therapeutics, Inc. Filed 2024-02-07 Acc 0000950170-24-012429

Documents 1

3/A , xslF345X02/ownership.xml

Around this filing

2024-02-08 144 Sale of Securities
2024-02-08 144 Sale of Securities
2024-02-08 424B5 Prospectus
2024-02-07 FWP Free Writing Prospectus
2024-02-07 4 Chief Medical Officer sold 24,552 shares at $30.05 ($737,788)
2024-02-07 3/A 3/A
2020-12-17 3/A 3/A

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslF345X02/ownership.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…